NIH launches clinical trial of three mRNA HIV vaccines
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial
Source: scienceblog.com
Page 29 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trials Network Today - Breaking & Trending Today
mRNA vaccine candidates for HIV enter Phase I trial
Will mRNA vaccines protect against HIV? Three investigational mRNA vaccines, all designed to combat HIV, have entered Phase I testing.
Source: europeanpharmaceuticalreview.com
HIV research: Clinical trial for Moderna's experimental vaccine will enroll participants in Philadelphia
A clinical trial for an experimental HIV vaccine will include Philadelphia as one of eight sites. The vaccine, developed by Moderna and Scripps Research Institute, relies on the mRNA technology that proved successful in the COVID-19 vaccines made by Pfizer and Moderna. In Philly, Penn Medicine will enroll participants.
Source: phillyvoice.com
NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.
Source: news-medical.net
Moderna, Inc.: Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA Vaccine
CAMBRIDGE, MA / ACCESSWIRE / March 14, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant
Source: finanznachrichten.de